These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7863014)

  • 41. Neurobiology of cholecystokinin.
    Moran TH; Schwartz GJ
    Crit Rev Neurobiol; 1994; 9(1):1-28. PubMed ID: 8828002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion.
    Hebb AL; Poulin JF; Roach SP; Zacharko RM; Drolet G
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Dec; 29(8):1225-38. PubMed ID: 16242828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholecystokinin in psychiatric research: a time for cautious excitement.
    Abelson JL
    J Psychiatr Res; 1995; 29(5):389-96. PubMed ID: 8748063
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Central cholecystokinin activity in irritable bowel syndrome, panic disorder, and healthy controls.
    Koszycki D; Torres S; Swain JE; Bradwejn J
    Psychosom Med; 2005; 67(4):590-5. PubMed ID: 16046372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Gastrin-/CCK-B antagonists are neuropharmacological tools].
    Oreland L
    Lakartidningen; 1995 Feb; 92(6):531-2. PubMed ID: 7853937
    [No Abstract]   [Full Text] [Related]  

  • 46. Receptor mediation of the stimulus properties of cholecystokinin.
    Melton PM; Riley AL
    Pharmacol Biochem Behav; 1994 May; 48(1):275-9. PubMed ID: 8029299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.
    Kõks S; Männistö PT; Bourin M; Shlik J; Vasar V; Vasar E
    J Psychiatry Neurosci; 2000 Jan; 25(1):33-42. PubMed ID: 10721682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endogenous cholecystokinin reduces feeding in young rats.
    Weller A; Smith GP; Gibbs J
    Science; 1990 Mar; 247(4950):1589-91. PubMed ID: 2321020
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aging and panicogenic response to cholecystokinin tetrapeptide: an examination of the cholecystokinin system.
    Flint A; Bradwejn J; Vaccarino F; Gutkowska J; Palmour R; Koszycki D
    Neuropsychopharmacology; 2002 Oct; 27(4):663-71. PubMed ID: 12377403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cholecystokinin system genes: associations with panic and other psychiatric disorders.
    Wilson J; Markie D; Fitches A
    J Affect Disord; 2012 Feb; 136(3):902-8. PubMed ID: 21978736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
    Ströhle A; Holsboer F; Rupprecht R
    Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peripheral and central cholecystokinin receptors regulate postprandial intestinal motility in the rat.
    Rodríguez-Membrilla A; Martínez V; Vergara P
    J Pharmacol Exp Ther; 1995 Oct; 275(1):486-93. PubMed ID: 7562590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology.
    Abelson JL; Nesse RM; Vinik AI
    Biol Psychiatry; 1994 Jul; 36(2):84-96. PubMed ID: 7524696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of central administration of the CCK-B receptor agonist pentagastrin on feeding and cortisol release in sheep.
    Ebenezer IS; Parrott RF
    Methods Find Exp Clin Pharmacol; 1996 May; 18(4):235-8. PubMed ID: 8803955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurobiology of panic disorder.
    Bourin M; Baker GB; Bradwejn J
    J Psychosom Res; 1998 Jan; 44(1):163-80. PubMed ID: 9483472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.
    Bradwejn J; Koszycki D; Shriqui C
    Arch Gen Psychiatry; 1991 Jul; 48(7):603-10. PubMed ID: 2069490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cholecystokinin and cholecystokinin receptor].
    Funakoshi A
    Nihon Rinsho; 1996 Apr; 54(4):1097-1103. PubMed ID: 8920681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clarification of the behavioral functions of peripheral and central cholecystokinin: two separate peptide pools.
    Crawley JN
    Peptides; 1985; 6 Suppl 2():129-36. PubMed ID: 3001671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of the 'central' cholecystokinin-B receptor in panic disorder.
    Megen HJ; Westenberg HG; Boer JA
    Acta Neuropsychiatr; 1996 Dec; 8(4):99-101. PubMed ID: 26964658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is premenstrual dysphoria a variant of panic disorder? A review.
    Vickers K; McNally RJ
    Clin Psychol Rev; 2004 Dec; 24(8):933-56. PubMed ID: 15533279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.